Open Access

Pineal parenchymal tumor of intermediate differentiation: Treatment outcomes of five cases

  • Authors:
    • Tsubasa Watanabe
    • Takashi Mizowaki
    • Yoshiki Arakawa
    • Yusuke Iizuka
    • Kengo Ogura
    • Katsuyuki Sakanaka
    • Susumu Miyamoto
    • Masahiro Hiraoka
  • View Affiliations

  • Published online on: December 23, 2013     https://doi.org/10.3892/mco.2013.231
  • Pages: 197-202
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Pineal parenchymal tumor of intermediate differentiation (PPTID) is a rare disease, first classified by the World Health Organization in 2000. The number of available studies on the treatment of PPTID is currrently limited and the optimal management for this disease has not yet been determined. We retrospectively evaluated the treatment outcomes for PPTID at our institute and analyzed the roles of radiation therapy and chemotherapy for this disease. The clinical data on five patients diagnosed with PPTID since 2000 were retrospectively reviewed. patients with cerebrospinal dissemination at diagnosis received biopsy‑only surgery, craniospinal and whole‑ventricular irradiation and chemotherapy. Patients with locally limited disease at diagnosis received local or whole‑ventricular irradiation after surgery. The median relapse‑free and overall survival were 72.9 and 94.1 months, respectively. Two of the five patients developed a relapse of cerebrospinal dissemination after treatment and succumbed to the disease. All the patients who received both craniospinal and whole‑ventricular irradiation exhibited evidence of cerebral white matter abnormalities in magnetic resonance imaging and developed neurocognitive disorders after treatment. Although PPTID may be aggressive and has cerebrospinal fluid seeding potential, PPTID patients may survive long‑term, even after recurrence. Considering the long survival time and the late adverse effects due to intensive treatment, the irradiation field and usage of chemotherapy after surgery require optimization.
View Figures
View References

Related Articles

Journal Cover

March 2014
Volume 2 Issue 2

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Watanabe, T., Mizowaki, T., Arakawa, Y., Iizuka, Y., Ogura, K., Sakanaka, K. ... Hiraoka, M. (2014). Pineal parenchymal tumor of intermediate differentiation: Treatment outcomes of five cases. Molecular and Clinical Oncology, 2, 197-202. https://doi.org/10.3892/mco.2013.231
MLA
Watanabe, T., Mizowaki, T., Arakawa, Y., Iizuka, Y., Ogura, K., Sakanaka, K., Miyamoto, S., Hiraoka, M."Pineal parenchymal tumor of intermediate differentiation: Treatment outcomes of five cases". Molecular and Clinical Oncology 2.2 (2014): 197-202.
Chicago
Watanabe, T., Mizowaki, T., Arakawa, Y., Iizuka, Y., Ogura, K., Sakanaka, K., Miyamoto, S., Hiraoka, M."Pineal parenchymal tumor of intermediate differentiation: Treatment outcomes of five cases". Molecular and Clinical Oncology 2, no. 2 (2014): 197-202. https://doi.org/10.3892/mco.2013.231